| Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia B Zhang, LXT Nguyen, L Li, D Zhao, B Kumar, H Wu, A Lin, F Pellicano, ... Nature medicine 24 (4), 450-462, 2018 | 137 | 2018 |
| STAT3 in tumor-associated myeloid cells: multitasking to disrupt immunity YL Su, S Banerjee, SV White, M Kortylewski International journal of molecular sciences 19 (6), 1803, 2018 | 103 | 2018 |
| Myeloid cell–targeted miR-146a mimic inhibits NF-κB–driven inflammation and leukemia progression in vivo YL Su, X Wang, M Mann, TP Adamus, D Wang, DF Moreira, Z Zhang, ... Blood, The Journal of the American Society of Hematology 135 (3), 167-180, 2020 | 98 | 2020 |
| STAT3 inhibition combined with CpG immunostimulation activates antitumor immunity to eradicate genetically distinct castration-resistant prostate cancers D Moreira, T Adamus, X Zhao, YL Su, Z Zhang, SV White, P Swiderski, ... Clinical Cancer Research 24 (23), 5948-5962, 2018 | 79 | 2018 |
| Combination of OipA, BabA, and SabA as candidate biomarkers for predicting Helicobacter pylori-related gastric cancer YL Su, HL Huang, BS Huang, PC Chen, CS Chen, HL Wang, PH Lin, ... Scientific reports 6 (1), 36442, 2016 | 54 | 2016 |
| Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity D Moreira, S Sampath, H Won, SV White, YL Su, M Alcantara, C Wang, ... The Journal of clinical investigation 131 (2), 2021 | 50 | 2021 |
| B cell lymphoma immunotherapy using TLR9-targeted oligonucleotide STAT3 inhibitors X Zhao, Z Zhang, D Moreira, YL Su, H Won, T Adamus, Z Dong, Y Liang, ... Molecular Therapy 26 (3), 695-707, 2018 | 29 | 2018 |
| Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML B Zhang, LXT Nguyen, D Zhao, DE Frankhouser, H Wang, DH Hoang, ... Journal of Hematology & Oncology 14, 1-19, 2021 | 15 | 2021 |
| Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia LXT Nguyen, B Zhang, DH Hoang, D Zhao, H Wang, H Wu, YL Su, ... Leukemia 35 (8), 2285-2298, 2021 | 13 | 2021 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016 C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ... Journal for ImmunoTherapy of Cancer 4, 107-221, 2016 | 12 | 2016 |
| The C-terminal disulfide bonds of Helicobacter pylori GroES are critical for IL-8 secretion via the TLR4-dependent pathway in gastric epithelial cells YL Su, JC Yang, H Lee, F Sheu, CH Hsu, SL Lin, LP Chow The Journal of Immunology 194 (8), 3997-4007, 2015 | 12 | 2015 |
| Beclin-1 as a neutrophil-specific immune checkpoint YL Su, M Kortylewski The Journal of Clinical Investigation 129 (12), 5079-5081, 2019 | 9 | 2019 |
| Importance of the C-terminal histidine residues of Helicobacter pylori GroES for Toll-like receptor 4 binding and interleukin-8 cytokine production H Lee, YL Su, BS Huang, FT Hsieh, YH Chang, SR Tzeng, CH Hsu, ... Scientific Reports 6 (1), 37367, 2016 | 7 | 2016 |
| Targeted in vivo delivery of NF-κB decoy inhibitor augments sensitivity of B cell lymphoma to therapy Z Zhang, X Zhao, D Wang, D Moreira, YL Su, M Alcantara, P Swiderski, ... Molecular Therapy 29 (3), 1214-1225, 2021 | 5 | 2021 |
| Targeted delivery of miRNA antagonists to myeloid cells in vitro and in vivo YL Su, P Swiderski, G Marcucci, M Kortylewski RNA interference and cancer therapy: methods and protocols, 141-150, 2019 | 4 | 2019 |
| Targeted marrow radiation (TMI) improves therapeutic efficacy of Stat3 decoy molecules by augmenting its delivery and immune modulation in an aml mouse model SS Madabushi, D Zuro, SU Yu-Lin, P Vishwasrao, J Brooks, LE Parra, ... Blood 134, 3929, 2019 | 2 | 2019 |
| Targeted Delivery of CpG-Mir-146a Mimic Oligonucleotides As a Therapeutic Strategy to Reduce NF-Κb-Mediated Pathogenic Inflammation and Myeloid Leukemia Progression SU Yu-Lin, Z Zhang, M Mann, X Wang, B Zhang, L Li, P Swiderski, ... Blood 132, 3501, 2018 | 2 | 2018 |
| Targeted Delivery of miR-146a Mimic Oligonucleotides as a Potential Therapeutic Approach to Modulate NF-kB Signaling in Myeloid Leukemia and Myeloproliferative Diseases Y Su, Z Zhang, P Swiderski, D Zeng, G Marcucci, M Boldin, M Kortylewski Experimental Hematology 64, S42, 2018 | 2 | 2018 |
| Targeted in vivo delivery of NF-κB decoy oligodeoxynucleotide augments efficacy of radiation therapy against B-cell lymphomas Z Zhang, X Zhao, D Moreira, YL Su, P Swiderski, S Forman, L Kwak, ... Cancer Research 80 (16_Supplement), 5356-5356, 2020 | 1 | 2020 |
| Microrna as a therapeutic agent MT Kortylewski, G Marcucci, YL Su, PM Swiderski US Patent App. 17/779,293, 2023 | | 2023 |
Marcin KortylewskiProfessor, Beckman Research Institute at City of Hope, CAVerified email at coh.org
